The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study
Abstract Background Tuberculosis (TB) preventive therapy is recommended for all people living with HIV (PLHIV). Despite the elevated risk of TB amongst PLHIV, most of those eligible for preventive therapy would never develop TB. Tests which can identify individuals at greatest risk of disease would...
Main Authors: | Tom Sumner, Simon C. Mendelsohn, Thomas J. Scriba, Mark Hatherill, Richard G. White |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-021-02127-w |
Similar Items
-
A novel blood test for tuberculosis prevention and treatment
by: A Penn-Nicholson, et al.
Published: (2017-01-01) -
Plasma host protein biomarkers correlating with increasing Mycobacterium tuberculosis infection activity prior to tuberculosis diagnosis in people living with HIV
by: Sarah N. Singer, et al.
Published: (2022-01-01) -
Low level of tuberculosis preventive therapy incompletion among people living with Human Immunodeficiency Virus in eastern Uganda: A retrospective data review
by: Paul Lwevola, et al.
Published: (2021-12-01) -
RESULTS OF ASSESSMENT OF SERVICES ON DETECTION AND DIAGNOSTICS OF TUBERCULOSIS PROVIDED TO PEOPLE LIVING WITH HIV
by: B.A. AKMATOVA
Published: (2018-08-01) -
Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis
by: Clay Roscoe, et al.
Published: (2020-12-01)